Athos Capital Ltd purchased a new position in shares of iKang Healthcare Group, Inc. (NASDAQ:KANG) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 702,708 shares of the medical research company’s stock, valued at approximately $8,622,000. iKang Healthcare Group makes up about 5.0% of Athos Capital Ltd’s investment portfolio, making the stock its 5th largest position.

Separately, First Manhattan Co. boosted its position in shares of iKang Healthcare Group by 101.7% in the second quarter. First Manhattan Co. now owns 1,040,043 shares of the medical research company’s stock worth $12,761,000 after buying an additional 524,318 shares during the period. 30.57% of the stock is currently owned by hedge funds and other institutional investors.

iKang Healthcare Group, Inc. (NASDAQ KANG) opened at 14.10 on Thursday. The stock’s market capitalization is $910.16 million. The company’s 50-day moving average is $12.65 and its 200-day moving average is $14.67. iKang Healthcare Group, Inc. has a 12 month low of $11.70 and a 12 month high of $19.20.

iKang Healthcare Group (NASDAQ:KANG) last released its quarterly earnings data on Thursday, June 22nd. The medical research company reported ($0.49) earnings per share for the quarter. iKang Healthcare Group had a negative return on equity of 3.19% and a negative net margin of 2.58%. The business had revenue of $60.16 million during the quarter. Equities research analysts forecast that iKang Healthcare Group, Inc. will post $0.65 EPS for the current year.

WARNING: “Athos Capital Ltd Takes Position in iKang Healthcare Group, Inc. (NASDAQ:KANG)” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at

Separately, BidaskClub raised shares of iKang Healthcare Group from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 5th.

iKang Healthcare Group Company Profile

iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.

Want to see what other hedge funds are holding KANG? Visit to get the latest 13F filings and insider trades for iKang Healthcare Group, Inc. (NASDAQ:KANG).

Receive News & Ratings for iKang Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.